cycloserine has been researched along with Anxiety in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 14 (56.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altemus, M; Anderson, P; Andersson, E; Cukor, J; Davis, M; de Kleine, RA; de la Cruz, LF; Difede, J; Dunlop, BW; Farrell, LJ; Finck, C; Frumento, P; Geffken, GR; Geller, D; Gerardi, M; Golfels, F; Goodman, WK; Guastella, AJ; Gutner, CA; Hendriks, GJ; Heyman, I; Hofmann, SG; Jovanovic, T; Kushner, MG; Lee, FS; Lenze, EJ; Levinson, CA; Lewin, AB; Mataix-Cols, D; McConnell, H; McNamara, JP; Monzani, B; Murphy, TK; Norrholm, S; Otto, MW; Pérez-Vigil, A; Plag, J; Pollack, MH; Ressler, KJ; Rodebaugh, TL; Rosenfield, D; Rothbaum, BO; Rück, C; Smits, JAJ; Storch, EA; Ströhle, A; Tart, CD; Thuras, P; Tolin, DF; Turner, C; van Minnen, A; Waters, AM; Weems, CF; Wilhelm, S; Wyka, K | 1 |
| Bae, YC; Cho, YS; Kang, M; Kim, D; Kim, E; Kim, K; Lee, EJ; Lee, H; Paoletti, P; Serraz, B; Shin, W | 1 |
| Oka, JI; Saitoh, A; Sugiyama, A; Yamada, M | 1 |
| Danaher, RJ; Lyons, DN; Ma, F; Miller, CS; Pandya, JD; Sirbu, C; Sullivan, PG; Westlund, KN; Zhang, L | 1 |
| Daniels, WMU; Fairbairn, L; Gamieldien, J; Hart, S; Hemmings, SMJ; Jalali Sefid Dashti, M; Kidd, M; Malan-Müller, S; Seedat, S | 1 |
| Hofmann, SG; Marques, L; Meuret, AE; Otto, MW; Pollack, MH; Roque, AD; Rosenfield, D; Simon, N; Smits, JAJ | 1 |
| Black, K; Koola, C; Norrholm, SD; Post, L; Rauch, SAM; Rothbaum, BO; Yasinski, C | 1 |
| Lee, J; Sandkühler, J | 1 |
| Dietrich, AD; Hanrahan, B; Johnson, PL; Lungwitz, EA; Schartz, N; Shekhar, A; Stuber, GD; Truitt, WA | 1 |
| Gomes, FV; Guimarães, FS; Hott, SC; Kakihata, AM; Resstel, LB; Semedo, AC; Uliana, DL | 1 |
| Maurer, V; Muigg, P; Murphy, C; Neumann, ID; Sartori, SB; Schmuckermair, C; Singewald, N; Whittle, N | 1 |
| Michopoulos, V | 1 |
| Grillon, C | 1 |
| Behar, E; McHugh, RK; Otto, MW; Peckham, A | 1 |
| Bidziński, A; Hamed, A; Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Sobolewska, A; Szyndler, J; Taracha, E; Turzyńska, D; Wisłowska-Stanek, A | 1 |
| Ho, SC; Ho, YJ; Pawlak, CR; Yeh, KY | 1 |
| Acha, J; Castillo, H; Guerra, D; Shin, S; Smith Fawzi, MC; Sweetland, A; Vega, P | 1 |
| Ho, YJ; Hsu, CC; Hsu, LS; Hsu, WY; Lai, TJ; Tsai, YF; Wang, CF | 1 |
| Dubrovina, NI; Tomilenko, RA | 2 |
| Bailey, JE; Lingford-Hughes, A; Nutt, DJ; Papadopoulos, A | 1 |
| Ho, YJ; Hsu, LS; Huang, YT; Pawlak, CR; Tu, WT; Wang, WF; Wu, SL | 1 |
| Moraes Ferreira, VM; Morato, GS | 1 |
| Biondi, L; Pasargiklian, M | 1 |
3 review(s) available for cycloserine and Anxiety
| Article | Year |
|---|---|
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
Topics: Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Child; Combined Modality Therapy; Cycloserine; Female; Humans; Implosive Therapy; Male; Middle Aged; Treatment Outcome; Young Adult | 2019 |
How to erase memory traces of pain and fear.
Topics: Analgesics, Opioid; Animals; Anxiety; Conditioning, Classical; Cycloserine; Extinction, Psychological; Fear; Humans; Hyperalgesia; Isoenzymes; Long-Term Potentiation; Memory, Long-Term; Mental Recall; Models, Neurological; Models, Psychological; Nerve Tissue Proteins; Neuroglia; Nociception; Pain; Pain Management; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Rats; Receptors, Ionotropic Glutamate | 2013 |
D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms.
Topics: Animals; Antimetabolites; Anxiety; Association Learning; Behavior Therapy; Conditioning, Classical; Cycloserine; Extinction, Psychological; Fear; Humans; Models, Psychological | 2009 |
4 trial(s) available for cycloserine and Anxiety
| Article | Year |
|---|---|
Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
Topics: Adult; Anxiety; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Female; Humans; Male; Phobia, Social; Treatment Outcome; Work | 2018 |
In session extinction and outcome in Virtual Reality Exposure Therapy for PTSD.
Topics: Adult; Alprazolam; Anxiety; Combined Modality Therapy; Cycloserine; Double-Blind Method; Extinction, Psychological; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy; Young Adult | 2018 |
D-cycloserine for the augmentation of an attentional training intervention for trait anxiety.
Topics: Adolescent; Adult; Aged; Anxiety; Attention; Behavior Therapy; Cycloserine; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychological Tests; Stress, Psychological; Young Adult | 2010 |
D-Cycloserine and performance under different states of anxiety in healthy volunteers.
Topics: Adolescent; Adult; Anxiety; Carbon Dioxide; Cognition; Cycloserine; Double-Blind Method; Excitatory Amino Acid Agonists; Fear; Female; Humans; Learning; Male; Pattern Recognition, Visual; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Space Perception | 2007 |
18 other study(ies) available for cycloserine and Anxiety
| Article | Year |
|---|---|
Early correction of synaptic long-term depression improves abnormal anxiety-like behavior in adult GluN2B-C456Y-mutant mice.
Topics: Animals; Anxiety; Behavior, Animal; Cycloserine; Excitatory Postsynaptic Potentials; Gene Knock-In Techniques; Haploinsufficiency; Heterozygote; Hippocampus; Long-Term Synaptic Depression; Mice, Mutant Strains; Mutation; Nerve Tissue Proteins; Receptors, N-Methyl-D-Aspartate | 2020 |
Administration of riluzole into the basolateral amygdala has an anxiolytic-like effect and enhances recognition memory in the rat.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Basolateral Nuclear Complex; Catheters, Indwelling; Cycloserine; Excitatory Amino Acid Antagonists; Male; Nootropic Agents; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Riluzole | 2017 |
Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury.
Topics: Analgesics; Animals; Anti-Anxiety Agents; Anxiety; Brain; Chronic Pain; Cognition; Cycloserine; Disease Models, Animal; Drug Therapy, Combination; Facial Pain; Hyperalgesia; Male; Mice, Inbred C57BL; Mitochondria; Neuralgia; Pioglitazone; Random Allocation; Trigeminal Nerve Injuries | 2018 |
The role of microRNAs in the therapeutic action of D-cycloserine in a post-traumatic stress disorder animal model: an exploratory study.
Topics: Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Cycloserine; Disease Models, Animal; Extinction, Psychological; Fear; High-Throughput Nucleotide Sequencing; Hippocampus; Male; Memory; MicroRNAs; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic | 2017 |
The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis.
Topics: Analysis of Variance; Animals; Antimetabolites; Anxiety; Cues; Cycloserine; Disease Models, Animal; Environment; GABA-A Receptor Agonists; Habituation, Psychophysiologic; Interpersonal Relations; Light; Male; Muscimol; Prefrontal Cortex; Rats; Rats, Wistar; Recognition, Psychology; Time Factors | 2014 |
D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
Topics: Animals; Anxiety; Cycloserine; Dose-Response Relationship, Drug; Locomotion; Male; Maze Learning; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2014 |
Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cognition; Conditioning, Classical; Cycloserine; Disease Models, Animal; Drug Therapy, Combination; Extinction, Psychological; Fear; Implosive Therapy; Male; Mice, 129 Strain; Neuropeptides; Rats, Inbred Strains; Recurrence; Time Factors | 2016 |
Enhancing cognitive behavioral therapy: Is the finish line in sight?
Topics: Anxiety; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic | 2017 |
The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Cycloserine; Disease Models, Animal; Drug Interactions; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Midazolam; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric | 2010 |
Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.
Topics: Animals; Anxiety; Brain; Cycloserine; Dementia; Hippocampus; Image Processing, Computer-Assisted; Immunohistochemistry; Interleukin-2; Male; Maze Learning; Microglia; MPTP Poisoning; Parkinson Disease; Postural Balance; Rats; Rats, Wistar; Recognition, Psychology | 2011 |
Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.
Topics: Adult; Age Distribution; Antibiotics, Antitubercular; Anxiety; Cycloserine; Depressive Disorder; Female; Humans; Incidence; Interview, Psychological; Male; Medical Records; Middle Aged; Mycobacterium tuberculosis; Peru; Psychoses, Substance-Induced; Tuberculosis, Multidrug-Resistant | 2004 |
Behavioral effects of d-cycloserine in rats: the role of anxiety level.
Topics: Animals; Antimetabolites; Anxiety; Behavior, Animal; Cycloserine; Exploratory Behavior; Male; Maze Learning; Rats; Rats, Wistar; Swimming | 2005 |
[Influence of activation and blockade of NMDA receptors on extinction of passive avoidance response in mice with different levels of anxiety].
Topics: Animals; Anxiety; Avoidance Learning; Cycloserine; Dizocilpine Maleate; Extinction, Psychological; Male; Maze Learning; Mice; Mice, Inbred C57BL; Reaction Time; Receptors, N-Methyl-D-Aspartate | 2006 |
Treatment for anxiety-related disorders.
Topics: Antidepressive Agents; Anxiety; Cycloserine; Drug Approval; Drug Industry; Georgia | 2007 |
Effects of activation and blockade of NMDA receptors on the extinction of a conditioned passive avoidance response in mice with different levels of anxiety.
Topics: Animals; Antimetabolites; Anxiety; Avoidance Learning; Conditioning, Classical; Cycloserine; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Extinction, Psychological; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index | 2007 |
Effects of D-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels.
Topics: Amygdala; Analysis of Variance; Animals; Antimetabolites; Anxiety; Cycloserine; Excitatory Amino Acid Agonists; Exploratory Behavior; Individuality; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Statistics, Nonparametric | 2008 |
D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze.
Topics: Animals; Anxiety; Behavior, Animal; Cycloserine; Dose-Response Relationship, Drug; Ethanol; Excitatory Amino Acid Agonists; Female; Male; Maze Learning; Pyrrolidinones; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1997 |
Neurologic and behavioural reactions of tuberculous patients treated with cycloserine.
Topics: Anxiety; Behavior; Cycloserine; Depression; Electroencephalography; Humans; Neurologic Manifestations; Tuberculosis | 1970 |